Clinuvel Pharmaceuticals Ltd (CUVL) › Cash & EquivalentsClinuvel Pharmaceuticals Ltd (CUVL): Cash & EquivalentsAnnual figures by period end, from SEC filings.$13.91MAs of 2026-06-30$18.06M2025-06-30: $18.06M2026-06-30: $13.91M$13.91M2025-06-30 Cash & Equivalents (USD) 2026-06-30Period endedCash & EquivalentsChange YoYSource filing2026-06-30$13.91M-23.0%2026-10-30, Balance as of period end2025-06-30$18.06Mn/a2026-10-30, Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)